Amy Cramer is Director on the Global Product Development Strategic Partnerships team, Pfizer. She draws on her experience as a cardiac critical care nurse, clinical research coordinator, certified healthcare quality professional and clinical research informaticist. She has worked in a community hospital, an independent academic medical center, and world class academic medical institution. Amy is Co-Chair for the HL7 FHIR Accelerator dedicated to Translational and Clinical Research, Vulcan, and Vice-Co-Chair for the Society for Clinical Data Management eSource Consortium. Amy’s focus throughout her career has been determining improvements that provide better patient-centric care, whether that be developing a visualization for a complex hypoglycemia protocol, developing a transplant quality program or optimizing the use of the electronic health record for clinical research. Amy’s current focus is on clinical trials solutions, which includes eSource; specifically, the secondary use of EHR data for clinical research. She is a previous Co-Chair of HL7 Clinical Interoperability Council. She is a TransCelerate member and reviewer for many professional journals. Amy received a Master’s in Management of Clinical Informatics from Duke University School of Medicine.